Tools

LEADER 02911nam 2200649 i 4500

001 ssj0002688212;

003 WaSeSS;

005 20221012080330.0;

006 m d ;

007 cr n ;

008 220902t20212021maua s 0|| 0 eng d;

010 a| 2021303346;

015 a| GBC1979162| bnb;

016 7 a| 0202347372| Uk;

020 a| 9780323853231;

020 a| 0323853234;

035 a| (WaSeSS)ssj0002688212;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| RB155.8b| .R473 2021;

082 04 a| 615.8952| 23;

245 00 a| Reprogramming the genomeh| [electronic resource] :b| CRISPR-Cas-based human disease therapy /c| edited by Vijai Singh, Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.;

250 a| First edition.;

260 a| Cambridge, MA :b| Academic Press, An Imprint of Elsevier,c| 2021.;

300 a| 376 pages :b| illustrations ;c| 23 cm.;

490 1 a| Progress in molecular biology and translational science ;v| 181;

504 a| Includes bibliographical references and index.;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

650 0 a| Gene therapy.=| ^A272727;

650 0 a| Gene editing.=| ^A1350639;

650 0 a| CRISPR activation.=| ^A1482746;

650 0 a| CRISPR-associated protein 9.=| ^A1350638;

650 2 a| Genetic Therapy=| ^A926617;

650 2 a| Gene Editing=| ^A1362025;

650 2 a| CRISPR-Associated Protein 9=| ^A1432329;

650 6 a| Thérapie génique.;

650 6 a| Édition génique.;

650 6 a| Protéine-9 associée à CRISPR.;

650 7 a| CRISPR activation.2| fast0| (OCoLC)fst02021912;

650 7 a| CRISPR-associated protein 9.2| fast0| (OCoLC)fst02000537;

650 7 a| Gene editing.2| fast0| (OCoLC)fst02000662;

650 7 a| Gene therapy.2| fast0| (OCoLC)fst00939638;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Singh, Vijai.?| UNAUTHORIZED;

830 0 a| Progress in molecular biology and translational science ;v| v. 181.=| ^A1030818;

856 40 z| Full text available from Book Series Package - Life Sciences [BSLFSC]u| https://go.openathens.net/redirector/ecu.edu?url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Fbookseries%2F18771173%2F181;

947 a| (OCoLC)on1237633796;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5926805;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5926805-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 10/14/2022x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5926805-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 10/14/2022x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5926805-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 10/14/2022x| EBOOKz| JERESOURCE;

Reprogramming the genome CRISPR-Cas-based human disease therapy / edited by Vijai Singh, Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.

Other author	Singh, Vijai.
Format	Electronic
Edition	First edition.
Publication Info	Cambridge, MA : Academic Press, An Imprint of Elsevier, 2021.
Description	376 pages : illustrations ; 23 cm.
Supplemental Content	Full text available from Book Series Package - Life Sciences [BSLFSC]
Subjects	Gene therapy. Gene editing. CRISPR activation. CRISPR-associated protein 9. Genetic Therapy Gene Editing CRISPR-Associated Protein 9 Thérapie génique. Édition génique. Protéine-9 associée à CRISPR.

Series	Progress in molecular biology and translational science ; 181 Progress in molecular biology and translational science ; v. 181. ^A1030818
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2021303346
ISBN	9780323853231
ISBN	0323853234

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Reprogramming the genome CRISPR-Cas-based human disease therapy / edited by Vijai Singh, Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, Gujarat, India.

Click here for more information about this title

Availability